Comparative performance and external validation of the multivariable PREDICT Prostate tool for non-metastatic prostate cancer: a study in 69,206 men from Prostate Cancer data Base Sweden (PCBaSe)-Reference-Cited by-同舟云学术

Comparative performance and external validation of the multivariable PREDICT Prostate tool for non-metastatic prostate cancer: a study in 69,206 men from Prostate Cancer data Base Sweden (PCBaSe)

Published:2020-06-16 Issue:1 Volume:18 Page:
ISSN:1741-7015
Container-title:BMC Medicine
language:en
Short-container-title:BMC Med

Author:

Thurtle David,Bratt Ola,Stattin Pär,Pharoah Paul,Gnanapragasam Vincent

Funder

The Urology Foundation

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12916-020-01606-w.pdf

Reference34 articles.

1. NPCA. National Prostate Cancer audit - annual report 2017. 2017.

2. Greenberg DC, Lophatananon A, Wright KA, Muir KR, Gnanapragasam VJ. Trends and outcome from radical therapy for primary non-metastatic prostate cancer in a UK population. PLoS One. 2015;10(3):e0119494.

3. Thurtle DR, Greenberg DC, Lee LS, Huang HH, Pharoah PD, Gnanapragasam VJ. Individual prognosis at diagnosis in nonmetastatic prostate cancer: development and external validation of the PREDICT Prostate multivariable model. PLoS Med. 2019;16(3):e1002758.

4. Predict Prostate Homepage. Available from: https://prostate.predict.nhs.uk/ . Accessed 29 Mar 2020.

5. NICE. Endorsed resource - Predict Prostate. Prostate cancer: diagnosis and management. 2019.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adaption and National Validation of a Tool for Predicting Mortality from Other Causes Among Men with Nonmetastatic Prostate Cancer;European Urology Oncology;2024-08

2. Combining Molecular Subtypes with Multivariable Clinical Models Has the Potential to Improve Prediction of Treatment Outcomes in Prostate Cancer at Diagnosis;Current Oncology;2022-12-22

3. Assessing the impact of MRI based diagnostics on pre-treatment disease classification and prognostic model performance in men diagnosed with new prostate cancer from an unscreened population;BMC Cancer;2022-08-11

4. Evaluation of Prognostic and Predictive Models in the Oncology Clinic;Clinical Oncology;2022-02

5. Clinical Impact of the Predict Prostate Risk Communication Tool in Men Newly Diagnosed with Nonmetastatic Prostate Cancer: A Multicentre Randomised Controlled Trial;European Urology;2021-11